NRAS and Miyoshi myopathy: All RAS-dependent MM lines harbored oncogenic RAS mutations, with the exception of KMS26 which expressed wild type KRAS. In contrast, EJM, JJN3, JK6L and XG6 expressed mutant isoforms of RAS but were not sensitive to KRAS or NRAS knockout.